dc.contributor.author | Ongen, Z. | |
dc.contributor.author | Guzelant, G. | |
dc.date.accessioned | 2021-03-02T22:21:45Z | |
dc.date.available | 2021-03-02T22:21:45Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Guzelant G., Ongen Z., "Multiple testing in the 'Canakinumab in atherosclerosis' trial: correction required?", CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, cilt.35, sa.2, 2017 | |
dc.identifier.issn | 0392-856X | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_0c3934b7-abee-4f83-aa9f-e4d75b25f228 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/13872 | |
dc.language.iso | eng | |
dc.subject | İç Hastalıkları | |
dc.subject | İmmünoloji ve Romatoloji | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | ROMATOLOJİ | |
dc.subject | Klinik Tıp | |
dc.title | Multiple testing in the 'Canakinumab in atherosclerosis' trial: correction required? | |
dc.type | Makale | |
dc.relation.journal | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 35 | |
dc.identifier.issue | 2 | |
dc.contributor.firstauthorID | 242434 | |